AFP and hepatocellular carcinoma: The AASLD and APASL guidelines differ on their recommendation of using serum AFP for risk assessment, as studies have demonstrated the lack of sensitivity and specificity of AFP in diagnosing HCC.40 41 Importantly, during the COVID-19 pandemic, there is acceptance in the field that HCC surveillance can be deferred,6 7 thus, both healthcare professionals and patients will have to accept delays in access to liver imaging in the short term.